Omni Medical Holdings Retains Westminster Securities Corporation

Business Wire, Sept 21, 2005

RAPID CITY, S.D. -- Omni Medical Holdings, Inc. (OTCBB:ONMH), a national provider of turn key back office solutions for medical practitioners and facilities, announced today that it is has engaged Westminster Securities Corporation as its financial advisor.

Omni CEO Arthur Lyons said, "We believe Westminster's involvement will add a new dimension to our corporate growth and long term success, especially with regard to corporate development, capital structure, acquisitions, and strategic partnerships."

About Omni Medical Holdings Inc.

Omni Medical Holdings, Inc. and its' subsidiaries provide a complete line of integrated back-office products for physicians and hospitals, including GE Centricity and Misys practice management and electronic medical records solutions, web based decision support reporting tools, data warehousing, disease management benchmarking, as well as medical billing and medical transcription services. Our ASP hosted products are designed to maximize practice performance by identifying ancillary revenue enhancement and cost savings opportunities, while eliminating the upfront costs and ongoing expense of owning, upgrading, staffing and maintaining multiple in-house operations and reporting systems.

About Westminster Securities Corporation:

Westminster Securities Corporation is a full service brokerage firm operating in five principal areas: Investment Banking, Research, Retail & Institutional Account Management, Execution Services, and Clearing and Operations. Founded in 1971, Westminster is a member of the New York Stock Exchange, National Association of Securities Dealers, and the Securities Investor Protection Corporation. Westminster is headquartered at 100 Wall Street, New York with branch offices in Atlanta, Cyprus, Miami, Shanghai, St. Louis, and Toronto.

FORWARD LOOKING STATEMENT:

Certain statements contained herein may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, 21E of the Exchange Act of 1934 and/or the Private Securities Litigation Reform Act of 1995. Such statements include, without limitation, statements regarding business plans, future regulatory environment and approval and the Company's ability to comply with the rules and policies of independent regulatory agencies. Although the Company believes the statements contained herein to be accurate as of the date they were made, it can give no assurance that such expectations will prove to be correct. The Company undertakes no obligation to update these forward-looking statements.